CRISPR

+$1.95 (+2.68%) As of 1:51 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRISPR and other ETFs, options, and stocks.

About CRSP

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA.

CEO
Samarth Kulkarni
Employees
473
Headquarters
Zug, Zug
Founded
2013

CRSP Key Statistics

Market cap
5.78B
Price-Earnings ratio
20.18
Dividend yield
—
Average volume
2.82M
High today
$75.41
Low today
$71.96
Open price
$71.96
Volume
249.75K
52 Week high
$150.76
52 Week low
$42.51

CRSP Earnings

-$2.32
$1.60
$5.52
$9.44
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Jul 28, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure